Skip to main content

A systematic literature and clinical guidelines review of medicines used for smoking cessation (CHERE)

Project Member(s): Viney, R., Goodall, S., Laba, T.

Funding or Partner Organisation: Department of Health
Department of Health

Start year: 2020

Summary: CHERE has been invited to prepare a proposal to undertake a systematic literature and clinical guidelines review of medicines used for smoking cessation. The project will comprise of three parts: i) a rapid scoping review of the literature ii) a comprehensive review of the clinical guidelines of the aforementioned medicines used for smoking cessation which will then be compared and contrasted to the TGA and PBS restrictions for these medicines, and iii) a systematic literature review of the clinical evidence (including safety and efficacy) of smoking cessation medicines, including combination therapies not currently PBS-listed, which will then be compared and contrasted to evidence already considered by the PBAC for smoking cessation therapy.

Publications:

Saing, S, van der Linden, N, Hayward, CS & Goodall, S 2018, 'PMD108 - COST-EFFECTIVENESS OF LEFT VENTRICULAR ASSIST DEVICES IN END STAGE HEART FAILURE USING STATE TRANSITION MODELLING BASED ON REGISTRY DATA', Elsevier BV, pp. S261-S261.
View/Download from: Publisher's site

FOR Codes: Health economics , Human Pharmaceutical Products, Evaluation of Health Outcomes, Health Economics